<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04657003</url>
  </required_header>
  <id_info>
    <org_study_id>17245</org_study_id>
    <secondary_id>I8F-MC-GPHL</secondary_id>
    <nct_id>NCT04657003</nct_id>
  </id_info>
  <brief_title>A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight</brief_title>
  <acronym>SURMOUNT-2</acronym>
  <official_title>Efficacy and Safety of Tirzepatide Once Weekly in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-2)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eli Lilly and Company</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eli Lilly and Company</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study of tirzepatide in participants with type 2 diabetes who have obesity or are&#xD;
      overweight. The main purpose is to learn more about how tirzepatide affects body weight. The&#xD;
      study will last 79 weeks (22 visits).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 29, 2021</start_date>
  <completion_date type="Anticipated">April 17, 2023</completion_date>
  <primary_completion_date type="Anticipated">March 20, 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent Change from Randomization in Body Weight</measure>
    <time_frame>Randomization, 72 Weeks</time_frame>
    <description>Percent Change from randomization in body weight</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of Participants Who Achieve ≥5% Body Weight Reduction from Randomization</measure>
    <time_frame>72 Weeks</time_frame>
    <description>Percentage of participants who achieve ≥5% body weight reduction from randomization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Achieve ≥10% Body Weight Reduction from Randomization</measure>
    <time_frame>72 Weeks</time_frame>
    <description>Percentage of participants who achieve ≥10% body weight reduction from randomization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Achieve ≥15% Body Weight Reduction from Baseline</measure>
    <time_frame>72 Weeks</time_frame>
    <description>Percentage of participants who achieve ≥15% body weight reduction from randomization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Randomization in Absolute Body Weight</measure>
    <time_frame>Randomization, 72 Weeks</time_frame>
    <description>Change from randomization in absolute body weight</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Randomization in Body Mass Index (BMI)</measure>
    <time_frame>Randomization, 72 Weeks</time_frame>
    <description>Change from randomization in BMI</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Randomization in HbA1c</measure>
    <time_frame>Randomization, 72 Weeks</time_frame>
    <description>Change from randomization in HbA1c</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants who Achieve HbA1c &lt;7%</measure>
    <time_frame>72 Weeks</time_frame>
    <description>Percentage of Participants who Achieve HbA1c &lt;7%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Achieve HbA1c ≤6.5%</measure>
    <time_frame>72 Weeks</time_frame>
    <description>Percentage of participants who achieve HbA1c ≤6.5%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants Who Achieve HbA1c &lt;5.7%</measure>
    <time_frame>72 Weeks</time_frame>
    <description>Percentage of participants who achieve HbA1c &lt;5.7%</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Randomization in Fasting Glucose</measure>
    <time_frame>Randomization, 72 Weeks</time_frame>
    <description>Change from randomization in fasting glucose</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Randomization in Waist Circumference</measure>
    <time_frame>Randomization, 72 Weeks</time_frame>
    <description>Change from randomization in waist circumference</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Randomization in Total Cholesterol</measure>
    <time_frame>Randomization, 72 Weeks</time_frame>
    <description>Change from randomization in total cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Randomization in Low Density Lipid (LDL)-Cholesterol</measure>
    <time_frame>Randomization, 72 Weeks</time_frame>
    <description>Change from randomization in LDL-cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Randomization in High Density Lipid (HDL) Cholesterol</measure>
    <time_frame>Randomization, 72 Weeks</time_frame>
    <description>Change from randomization in HDL cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Randomization in Very Low Density Lipid (VLDL) Cholesterol</measure>
    <time_frame>Randomization, 72 Weeks</time_frame>
    <description>Change from randomization in VLDL cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Randomization in Triglycerides</measure>
    <time_frame>Randomization, 72 Weeks</time_frame>
    <description>Change from randomization in triglycerides</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Randomization in Free Fatty Acids</measure>
    <time_frame>Randomization, 72 Weeks</time_frame>
    <description>Change from randomization in free fatty acids</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Randomization in Systolic Blood Pressure (SBP)</measure>
    <time_frame>Randomization, 72 Weeks</time_frame>
    <description>Change from randomization in SBP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Randomization in Diastolic Blood Pressure (DBP)</measure>
    <time_frame>Randomization, 72 Weeks</time_frame>
    <description>Change from randomization in DBP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Randomization in Fasting Insulin</measure>
    <time_frame>Randomization, 72 Weeks</time_frame>
    <description>Change from randomization in fasting insulin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Randomization in Short Form 36 Health Survey version 2 (SF-36v2) acute form Physical Functioning domain score</measure>
    <time_frame>Randomization, 72 Weeks</time_frame>
    <description>The Short Form 36 Version 2 (SF-36v2 ) acute form, 1-week recall, assesses participants' health-related quality of life (HRQoL) on 8 domains: 1) limitations in physical functioning; 2) limitations in usual role because of physical health problems; 3) bodily pain; 4) general health perceptions; 5) vitality; 6) limitations in social functioning; 7) limitations in usual role due to emotional problems; and 8) general mental health. Domain scores are norm-based and presented in the form of T-scores, with a mean of 50 and standard deviation of 10, with higher scores indicating better levels of function and/or better health.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Randomization in Impact of Weight on Quality of Life-Lite-Clinical Trials Version (IWQOL Lite-CT) Physical Function Composite Score</measure>
    <time_frame>Randomization, 72 Weeks</time_frame>
    <description>The IWQOL Lite-CT consists of 20 items, assessing 2 primary domains of obesity related HRQoL: Physical (7 items) and Psychosocial (13 items). A 5 item subset of the Physical domain - the Physical Function composite - is also supported. Items in the Physical Function composite describe physical impacts related to general and specific physical activities. Individual composite scale scores and a total score can be computed and are presented on a scale of 0 to 100, with higher scores indicating better function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pharmacokinetics (PK): Steady State Area Under the Concentration Curve (AUC) of Tirzepatide</measure>
    <time_frame>Baseline through Week 72</time_frame>
    <description>PK: Steady State AUC of Tirzepatide</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">900</enrollment>
  <condition>Type 2 Diabetes</condition>
  <condition>Overweight</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>10 mg Tirzepatide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 mg Tirzepatide administered subcutaneously (SC)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>15 mg Tirzepatide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>15 mg Tirzepatide administered SC</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo administered SC</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tirzepatide</intervention_name>
    <description>Administered SC</description>
    <arm_group_label>10 mg Tirzepatide</arm_group_label>
    <arm_group_label>15 mg Tirzepatide</arm_group_label>
    <other_name>LY3298176</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Administered SC</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Have Type 2 Diabetes (T2DM) with HbA1c ≥7% to ≤10% at screening, on stable therapy for&#xD;
             the last 3 months prior to screening. T2DM may be treated with diet/exercise alone or&#xD;
             any oral glycemic-lowering agent (as per local labeling) EXCEPT dipeptidyl peptidase 4&#xD;
             (DPP-4) inhibitors or glucagon like peptide-1 receptor agonists (GLP-1 RAs)&#xD;
&#xD;
          -  Have a BMI of ≥27 kg/m²&#xD;
&#xD;
          -  Are overweight or have obesity&#xD;
&#xD;
          -  Have a history of at least 1 self-reported unsuccessful dietary effort to lose body&#xD;
             weight&#xD;
&#xD;
          -  Are at least 18 years of age and age of majority per local laws and regulations&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Have Type 1 diabetes mellitus, history of ketoacidosis or hyperosmolar state/coma or&#xD;
             any other types of diabetes except T2DM&#xD;
&#xD;
          -  Have at least 2 confirmed fasting self-monitoring blood glucose (SMBG) values &gt;270&#xD;
             mg/dL(on 2 nonconsecutive days) prior to Visit 3&#xD;
&#xD;
          -  Have proliferative diabetic retinopathy OR diabetic macular edema OR non-proliferative&#xD;
             diabetic retinopathy that requires acute treatment&#xD;
&#xD;
          -  Have self-reported change in body weight &gt;5kg within 3 months prior to screening&#xD;
&#xD;
          -  Have had a history of chronic or acute pancreatitis&#xD;
&#xD;
          -  Change in body weight greater than 5 kg within 3 months prior to starting study&#xD;
&#xD;
          -  Obesity induced by other endocrinologic disorders or monogenetic or syndromic forms of&#xD;
             obesity&#xD;
&#xD;
          -  Family or personal history of medullary thyroid carcinoma (MTC) or multiple endocrine&#xD;
             neoplasia syndrome type 2 (MEN-2)&#xD;
&#xD;
          -  History of significant active or unstable major depressive disorder (MDD) or other&#xD;
             severe psychiatric disorder within the last 2 years&#xD;
&#xD;
          -  Any lifetime history of a suicide attempt&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)</last_name>
    <role>Study Director</role>
    <affiliation>Eli Lilly and Company</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or</last_name>
    <phone>1-317-615-4559</phone>
    <email>ClinicalTrials.gov@lilly.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Alabama - Department of Nutrition Sciences</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35294</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>205-996-4733</phone>
    </contact>
    <investigator>
      <last_name>William Garvey</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>KLR Business Group, Inc. dba Arkansas Clinical Research</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>501-907-9169</phone>
    </contact>
    <investigator>
      <last_name>Kevin D Roberts</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Research Institute - Huntington Park</name>
      <address>
        <city>Huntington Park</city>
        <state>California</state>
        <zip>90255</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>323-588-1968</phone>
    </contact>
    <investigator>
      <last_name>Stanley H. Hsia</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Research Institute - Wilshire</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90057</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>2134132500</phone>
    </contact>
    <investigator>
      <last_name>Juan Pablo Frias</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Catalina Research Institute, LLC</name>
      <address>
        <city>Montclair</city>
        <state>California</state>
        <zip>91763</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>909-590-8409</phone>
    </contact>
    <investigator>
      <last_name>Rizwana H Mohseni</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Encompass Clinical Research</name>
      <address>
        <city>Spring Valley</city>
        <state>California</state>
        <zip>91978</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>619-660-9068</phone>
    </contact>
    <investigator>
      <last_name>Hanid Audish</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Clinical Investigators, Inc.</name>
      <address>
        <city>Tustin</city>
        <state>California</state>
        <zip>92780</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>714-734-7944</phone>
    </contact>
    <investigator>
      <last_name>Joanna T. Van</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06519</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>203-785-7421</phone>
    </contact>
    <investigator>
      <last_name>Ania M. Jastreboff</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ALL Medical Research, LLC</name>
      <address>
        <city>Cooper City</city>
        <state>Florida</state>
        <zip>33024</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>754-263-2000</phone>
    </contact>
    <investigator>
      <last_name>Lorena Lewy-Alterbaum</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northeast Research Institute (NERI)</name>
      <address>
        <city>Fleming Island</city>
        <state>Florida</state>
        <zip>32003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>904-541-8225</phone>
    </contact>
    <investigator>
      <last_name>Senan Sultan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>New Horizon Research Center</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33165</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>305-226-3933</phone>
    </contact>
    <investigator>
      <last_name>Lazaro D. Nunez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>West Orange Endocrinology</name>
      <address>
        <city>Ocoee</city>
        <state>Florida</state>
        <zip>34761</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>(407) 480-4830</phone>
    </contact>
    <investigator>
      <last_name>Jose Manuel Mandry</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Metabolic Research Institute, Inc.</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>5618023060</phone>
    </contact>
    <investigator>
      <last_name>Barry Scot Horowitz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Emory University School of Medicine- Grady Campus</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>347-901-3464</phone>
    </contact>
    <investigator>
      <last_name>Rodolfo J Galindo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Atlanta Diabetes Associates</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30318</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>678-237-1005</phone>
    </contact>
    <investigator>
      <last_name>Bruce Bode</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>East Coast Institute for Research at The Jones Center</name>
      <address>
        <city>Macon</city>
        <state>Georgia</state>
        <zip>31210</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>478-219-2017</phone>
    </contact>
    <investigator>
      <last_name>Thomas Cunningham Jones</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pacific Diabetes &amp; Endocrine Center</name>
      <address>
        <city>Honolulu</city>
        <state>Hawaii</state>
        <zip>96813</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>ALAN PARSA</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Elite Clinical Trials</name>
      <address>
        <city>Blackfoot</city>
        <state>Idaho</state>
        <zip>83221</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>208-643-0006</phone>
    </contact>
    <investigator>
      <last_name>Gary W Soucie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rocky Mountain Clinical Research</name>
      <address>
        <city>Idaho Falls</city>
        <state>Idaho</state>
        <zip>83404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>208-522-6005</phone>
    </contact>
    <investigator>
      <last_name>Carl D Vance</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Elite Clinical Trials</name>
      <address>
        <city>Rexburg</city>
        <state>Idaho</state>
        <zip>83440</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>208-643-0006</phone>
    </contact>
    <investigator>
      <last_name>Gary W Soucie</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>American Health Network of IN, LLC</name>
      <address>
        <city>Greenfield</city>
        <state>Indiana</state>
        <zip>46140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>317-462-8011</phone>
    </contact>
    <investigator>
      <last_name>Talessa Powell</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Iowa Diabetes and Endocrinology Research Center</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <zip>50265</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>515-329-6800</phone>
    </contact>
    <investigator>
      <last_name>Anuj Bhargava</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cotton O'Neil Clinic</name>
      <address>
        <city>Topeka</city>
        <state>Kansas</state>
        <zip>66606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>785-354-9591</phone>
    </contact>
    <investigator>
      <last_name>susan brian</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maryland Cardiovascular Specialists</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>443-798-2670</phone>
    </contact>
    <investigator>
      <last_name>Carlos S Ince</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>MD Medical Research</name>
      <address>
        <city>Oxon Hill</city>
        <state>Maryland</state>
        <zip>20745</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>301-839-2008</phone>
    </contact>
    <investigator>
      <last_name>Stephen Ong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>NECCR PrimaCare Research</name>
      <address>
        <city>Fall River</city>
        <state>Massachusetts</state>
        <zip>02721</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>508-672-7450</phone>
    </contact>
    <investigator>
      <last_name>Tamer Yacoub</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arcturus Healthcare , PLC, Troy Internal Medicine Research Division</name>
      <address>
        <city>Troy</city>
        <state>Michigan</state>
        <zip>48098</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>248-312-0026</phone>
    </contact>
    <investigator>
      <last_name>Neil J. Fraser</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Logan Health Research</name>
      <address>
        <city>Kalispell</city>
        <state>Montana</state>
        <zip>59901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Jose de Souza</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Premier Research</name>
      <address>
        <city>Trenton</city>
        <state>New Jersey</state>
        <zip>08611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>609-392-6666</phone>
    </contact>
    <investigator>
      <last_name>Jane L. Rohlf</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of North Carolina Medical Center</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27514</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>716-228-4491</phone>
    </contact>
    <investigator>
      <last_name>Sriram Machineni</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PharmQuest</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27408</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>3365748020</phone>
    </contact>
    <investigator>
      <last_name>Alexander Vance Murray</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wake Forest University Baptist Medical Center (WFUBMC)</name>
      <address>
        <city>Winston-Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>336-716-6722</phone>
    </contact>
    <investigator>
      <last_name>Jamy Ard</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Velocity Clinical Research, Cleveland</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>216-682-0320</phone>
    </contact>
    <investigator>
      <last_name>Toby Briskin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Aventiv Research</name>
      <address>
        <city>Dublin</city>
        <state>Ohio</state>
        <zip>43016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>614-336-7880</phone>
    </contact>
    <investigator>
      <last_name>Roy C St. John</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Corvallis Clinic, P.C.</name>
      <address>
        <city>Corvallis</city>
        <state>Oregon</state>
        <zip>97330</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>541-754-1398</phone>
    </contact>
    <investigator>
      <last_name>Brian M Curtis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Preferred Primary Care Physicians</name>
      <address>
        <city>Uniontown</city>
        <state>Pennsylvania</state>
        <zip>15401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>724-912-0033</phone>
    </contact>
    <investigator>
      <last_name>Paul A. Hartley</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Velocity Clinical Research, Providence</name>
      <address>
        <city>Warwick</city>
        <state>Rhode Island</state>
        <zip>02886</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>401-739-9350</phone>
    </contact>
    <investigator>
      <last_name>David L. Fried</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tribe Clinical Research, LLC</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29607</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>8643340141</phone>
    </contact>
    <investigator>
      <last_name>Ronald Keith Mayfield</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Diabetes &amp; Endocrinology, P.A.</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78749</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>512-334-3505</phone>
    </contact>
    <investigator>
      <last_name>Tira Chaicha- Brom</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dallas Diabetes Research Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>972-566-7799</phone>
    </contact>
    <investigator>
      <last_name>Julio Rosenstock</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Diabetes and Thyroid Center of Fort Worth</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76132</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>817-263-0007</phone>
    </contact>
    <investigator>
      <last_name>Anjanette Tan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Juno Research - Gessner</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77074</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>713-779-5494</phone>
    </contact>
    <investigator>
      <last_name>Audrey T. Lacour</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Endocrine Ips, Pllc</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77079</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>713-973-3415</phone>
    </contact>
    <investigator>
      <last_name>Amer S Al-Karadsheh</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Health Research of Hampton Roads, Inc.</name>
      <address>
        <city>Newport News</city>
        <state>Virginia</state>
        <zip>23606</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>757-591-8100</phone>
    </contact>
    <investigator>
      <last_name>George H Freeman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rainier Clinical Research Center</name>
      <address>
        <city>Renton</city>
        <state>Washington</state>
        <zip>98057</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>425-251-1720</phone>
    </contact>
    <investigator>
      <last_name>Leslie J Klaff</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinical Investigation Specialists</name>
      <address>
        <city>Kenosha</city>
        <state>Wisconsin</state>
        <zip>53144</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>262-925-1280</phone>
    </contact>
    <investigator>
      <last_name>Bharathi Pulla</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CIPREC-Centro de Investigacion y Prevencion Cardiovascular-</name>
      <address>
        <city>Caba</city>
        <state>Buenos Aires</state>
        <zip>C1119ACN</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>541148273866</phone>
    </contact>
    <investigator>
      <last_name>Cesar Javier Zaidman</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Consultorio de Investigación Clínica EMO SRL</name>
      <address>
        <city>Ciudad Autonoma de Buenos Aire</city>
        <state>Buenos Aires</state>
        <zip>C1405BUB</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+5491157417654</phone>
    </contact>
    <investigator>
      <last_name>Pablo Rene Costanzo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro de Investigaciones Metabólicas (CINME)</name>
      <address>
        <city>Ciudad Autónoma de Buenos Aire</city>
        <state>Buenos Aires</state>
        <zip>1056</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>00541150319914</phone>
    </contact>
    <investigator>
      <last_name>Federico C. Perez Manghi</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto de Investigaciones Clínicas Mar del Plata</name>
      <address>
        <city>Mar del Plata</city>
        <state>Buenos Aires</state>
        <zip>7600</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+54 223 496 3224</phone>
    </contact>
    <investigator>
      <last_name>Ignacio MacKinnon</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Go Centro Medico San Nicolás</name>
      <address>
        <city>San Nicolas</city>
        <state>Buenos Aires</state>
        <zip>2900</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>5493415597777</phone>
    </contact>
    <investigator>
      <last_name>Marisa Liliana Vico</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro Médico Viamonte</name>
      <address>
        <city>Buenos Aires</city>
        <state>Ciudad Autónoma De Buenos Aire</state>
        <zip>C1120AAC</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+54 1149635650</phone>
    </contact>
    <investigator>
      <last_name>Diego Aizenberg</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro de Investigaciones Médicas Tucuman</name>
      <address>
        <city>SAN M. DE Tucuman</city>
        <state>Tucumán</state>
        <zip>T4000AXL</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+54 9 381 4968313</phone>
    </contact>
    <investigator>
      <last_name>Leonardo Pablo Serra</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sanatorio Norte</name>
      <address>
        <city>Santiago del Estero</city>
        <zip>4200</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>0384154125573</phone>
    </contact>
    <investigator>
      <last_name>Franklin Hector Abalos</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Private Practice - Dr.Miguel N. Hissa</name>
      <address>
        <city>Fortaleza</city>
        <state>Ceará</state>
        <zip>60160-140</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>55 85 996299242</phone>
    </contact>
    <investigator>
      <last_name>Viviane Rocha Nasser Hissa</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Loema Instituto de Pesquisa Clinica</name>
      <address>
        <city>Campinas</city>
        <state>São Paulo</state>
        <zip>13010-001</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>5519 32353575</phone>
    </contact>
    <investigator>
      <last_name>Maria Helena Vidotti</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Instituto de Pesquisa clinica de Campinas</name>
      <address>
        <city>Campinas</city>
        <state>São Paulo</state>
        <zip>13060-080</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>1932670023</phone>
    </contact>
    <investigator>
      <last_name>Jose Francisco Kerr Saraiva</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CECIP - Centro de Estudos do Interior Paulista</name>
      <address>
        <city>Jaú</city>
        <state>São Paulo</state>
        <zip>17201130</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+551436220500</phone>
    </contact>
    <investigator>
      <last_name>Octavio de Marques Freitas Morato</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CPCLIN</name>
      <address>
        <city>Sao Paulo</city>
        <state>São Paulo</state>
        <zip>01228-200</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+551127110298</phone>
    </contact>
    <investigator>
      <last_name>Denise Reis Franco</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CEPIC - Centro Paulista de Investigação Clínica</name>
      <address>
        <city>São Paulo</city>
        <zip>04266-010</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+551122713450</phone>
    </contact>
    <investigator>
      <last_name>Breno Balabem Alves</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>All India Institute of Medical Sciences</name>
      <address>
        <city>New Delhi</city>
        <state>Delhi</state>
        <zip>110029</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <phone>91-11-26593237</phone>
    </contact>
    <investigator>
      <last_name>Rajesh Khadgawat</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Life Care Hospital and Research Centre</name>
      <address>
        <city>Bangalore</city>
        <state>Karnataka</state>
        <zip>560092</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>918023631055</phone>
    </contact>
    <investigator>
      <last_name>Sreenivasa Murthy</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ILS Hospitals</name>
      <address>
        <city>Kolkata</city>
        <state>West Bengal</state>
        <zip>700064</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>09830400450</phone>
    </contact>
    <investigator>
      <last_name>Ghanshyam Goyal</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical Corporation Yuga Tsuruma Kaneshiro Diabetes Clinic</name>
      <address>
        <city>Yamato-shi</city>
        <state>Kanagawa</state>
        <zip>242-0004</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>81120023812</phone>
    </contact>
    <investigator>
      <last_name>Taro Asakura</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Medical Corporation Heishinkai OCROM Clinic</name>
      <address>
        <city>Suita-shi</city>
        <state>Osaka</state>
        <zip>565-0853</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>81120023812</phone>
    </contact>
    <investigator>
      <last_name>Satoshi Inoue</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sato Medical Clinic</name>
      <address>
        <city>Ootaku</city>
        <state>Tokyo</state>
        <zip>143-0015</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>81120023812</phone>
    </contact>
    <investigator>
      <last_name>Nobuyuki Sato</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AMC Nishiumeda Clinic</name>
      <address>
        <city>Osaka</city>
        <zip>530-0001</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>81120023812</phone>
    </contact>
    <investigator>
      <last_name>Yoshimitsu Yamasaki</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Centro de Endocrinologia y Nutricion</name>
      <address>
        <city>Caguas</city>
        <zip>725</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>7879615046</phone>
    </contact>
    <investigator>
      <last_name>Juan R Otero-Martinez</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Latin Clinical Trial Center</name>
      <address>
        <city>San Juan</city>
        <zip>909</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>7879859911</phone>
    </contact>
    <investigator>
      <last_name>Alex Gonzalez-Bossolo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>GCM Medical Group, PSC - Hato Rey Site</name>
      <address>
        <city>San Juan</city>
        <zip>917</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>7876191117</phone>
    </contact>
    <investigator>
      <last_name>Gregorio A. Cortes-Maisonet</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Endocrinology Research Center of Rosmedtechnologies</name>
      <address>
        <city>Moscow</city>
        <state>Moskva</state>
        <zip>117036</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>89162161767</phone>
    </contact>
    <investigator>
      <last_name>Marina V Shestakova</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Endocrinology Research Center of Rosmedtechnologies</name>
      <address>
        <city>Moscow</city>
        <state>Moskva</state>
        <zip>117036</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+74951243502</phone>
    </contact>
    <investigator>
      <last_name>Ekaterina Troshina</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Russian Medical Academy of Postgraduate Education</name>
      <address>
        <city>Moscow</city>
        <state>Moskva</state>
        <zip>125284</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+7 985 222 2915</phone>
    </contact>
    <investigator>
      <last_name>Alexander Ametov</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saint-Petersburg City Hospital of Saint Elizabeth</name>
      <address>
        <city>Санкт-Петербург</city>
        <state>Sankt-Peterburg</state>
        <zip>195257</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+79219363555</phone>
    </contact>
    <investigator>
      <last_name>Natalia V. Vorokhobina</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Smolensk State Medical University</name>
      <address>
        <city>Smolensk</city>
        <zip>214019</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>+79101179149</phone>
    </contact>
    <investigator>
      <last_name>Elena Vitalyevna Khaykina</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Changhua Christian Hospital</name>
      <address>
        <city>Changhua County</city>
        <state>Changhua</state>
        <zip>50006</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>88647238595</phone>
    </contact>
    <investigator>
      <last_name>Shih-Te Tu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chi Mei Medical Center</name>
      <address>
        <city>Tainan City</city>
        <state>Tainan</state>
        <zip>71004</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Chwen-Yi Yang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chung Shan Medical University Hospital</name>
      <address>
        <city>Taichung</city>
        <zip>402</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>886424739595</phone>
    </contact>
    <investigator>
      <last_name>Chien-Ning Huang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Taichung Veterans General Hospital</name>
      <address>
        <city>Taichung</city>
        <zip>407</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>886423592525</phone>
    </contact>
    <investigator>
      <last_name>I-Te Lee</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>National Cheng-Kung Uni. Hosp.</name>
      <address>
        <city>Tainan</city>
        <zip>704</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <phone>88662353535</phone>
    </contact>
    <investigator>
      <last_name>Horng-Yih Ou</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Brazil</country>
    <country>India</country>
    <country>Japan</country>
    <country>Puerto Rico</country>
    <country>Russian Federation</country>
    <country>Taiwan</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Mexico</country>
  </removed_countries>
  <link>
    <url>https://trials.lillytrialguide.com/en-US/trial/6Lso9L1WmsU8ly9DkEFiaU</url>
    <description>A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight (SURMOUNT-2)</description>
  </link>
  <verification_date>November 15, 2021</verification_date>
  <study_first_submitted>December 1, 2020</study_first_submitted>
  <study_first_submitted_qc>December 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 7, 2020</study_first_posted>
  <last_update_submitted>November 17, 2021</last_update_submitted>
  <last_update_submitted_qc>November 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Metabolism and Nutrition Disorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tirzepatide</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Anonymized individual patient level data will be provided in a secure access environment upon approval of a research proposal and a signed data sharing agreement.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_time_frame>Time Frame:&#xD;
Data are available 6 months after the primary publication and approval of the indication studied in the US and European Union (EU), whichever is later. Data will be indefinitely available for requesting.</ipd_time_frame>
    <ipd_access_criteria>A research proposal must be approved by an independent review panel and researchers must sign a data sharing agreement.</ipd_access_criteria>
    <ipd_url>https://www.vivli.org/</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

